Clinical Trials
3 trialsNCT04036721 2023-02-23
PROS-CONS
National Institute for Tuberculosis and Lung Diseases, Poland
Phase 4 Suspended
NCT01320501 2016-05-13
REALME
National Guard Health Affairs
Phase 4 Suspended
NCT01720901 2015-05-22
Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy
Betta Pharmaceuticals Co., Ltd.
Phase 4 Suspended